•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Aurora is expanding its global medical cannabis portfolio, aiming to deliver consistency and reliability across the markets it serves. Lana Culley, VP Innovation & International Operations at Aurora, said the company is responding to patient and prescriber demand by offering products that meet local regulatory standards, provide meaningful choice across formats, and can be supplied reliably at scale.
The new products are designed to align with Aurora’s medical-first strategy and leverage the company’s global GMP-certified manufacturing network. Aurora said the expanded medical cannabis offerings will roll out in their respective markets between now and June.
Aurora said the launches underscore its role in advancing regulated medical cannabis globally, supporting growth in these markets through high-quality products, diverse formats, and reliable supply.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
